New Cancer Therapies Linked To High Blood Pressure
New cancer therapies, particularly agents that block vascular endothelial growth factor (VEGF) signaling, have been successful and are now used as a first line therapy for some tumors, but almost 100% of patients who take VEGF inhibitors (VEGFIs) develop high blood pressure, and a subset develops severe hypertension.
The mechanisms underlying VEGF inhibitor-induced hypertension need to be better understood and there is a need for clear guidelines and improved management, say investigators behind the review in the Canadian Journal of Cardiology.
"Exactly how VEGFIs cause hypertension is…